What is Eikon Therapeutics, Inc. 's total current assets?

Eikon Therapeutics, Inc. (EIKN) reported total current assets of $529.5M in Q1 2026.

What does total current assets mean?

The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

MYR GroupMYRG

$1.09B+12.1%

Cabot CorporationCBT

$1.55B-3.5%

UnifirstUNF

$903.09M-3.6%

HES

Hess MidstreamHESM

$165.8M+10.5%

BeldenBDC

$1.28B+13.0%

Alkami Technology, Inc.ALKT

$169.54M-2.7%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's total current assets?: Eikon Therapeutics, Inc. (EIKN) reported total current assets of $529.5M in Q1 2026.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.